KEYMED BIO-B is listed in Hong Kong. Sector: Healthcare. Industry: Biotechnology.
KEYMED BIO-B (02162): research close 68.35 HKD on 2026-11-17. 52-week range 46.34 to 87.20 HKD. Sector: Healthcare. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 68.35 HKD | 2026-11-17 |
| Previous research close | 69.00 HKD | 2026-11-16 |
| Change between the two dated research closes | -0.94% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 20.42 billion HKD | 2026-11-17 |
| 52-week range of the research close | 46.34 – 87.20 HKD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 13.44% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 209.96 million HKD | 2026-11-17 |
Source: hk_prices_research_v1 · HK · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save 02162 to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate